Assoc. Prof. Dr BEATRICE PERISSUTTI | Pharmaceutical Science | Women Researcher Award |

Posted on by ScienceFather

Assoc. Prof. Dr BEATRICE PERISSUTTI | Pharmaceutical Science | Women Researcher Award |

University of Trieste, Italy

Professional Profiles:

SCOPUS

ORCID

👨‍🎓 Bio Summary:

Assoc. Prof. Dr. Beatrice Perissutti is an accomplished academic and researcher in Pharmaceutical Technology, currently serving as an Associate Professor at the University of Trieste in the Department of Chemical and Pharmaceutical Sciences. With a specialization in the design and development of solid oral dosage forms for active pharmaceutical ingredients (APIs) with poor bioavailability, her research focuses on the solid-state properties of APIs, including anhydrous polymorphs, hydrates, solvates, amorphous forms, co-amorphous forms, and cocrystals. Using mechanochemical activation techniques, she has made significant strides in enhancing API stability and bioavailability. Dr. Perissutti has successfully balanced her career in academia with her personal life as a mother of four, demonstrating resilience and dedication to both scientific research and family. Her contributions have been pivotal in advancing pharmaceutical sciences, making her a respected figure in her field.

🎓 Educational Background:

Assoc. Prof. Dr. Beatrice Perissutti has an outstanding academic background, earning her degree in Pharmaceutical Sciences from the University of Trieste. She further specialized in Pharmaceutical Technology, a field in which she holds a Ph.D., demonstrating a profound commitment to advancing drug formulation and technology.

🔍 Research Focus:

Dr. Perissutti’s research is centered on the design and development of solid oral dosage forms for active pharmaceutical ingredients (APIs) with poor bioavailability. She is particularly interested in the solid-state properties of APIs, focusing on anhydrous polymorphs, hydrates, solvates, amorphous forms, co-amorphous forms, and cocrystals. Her innovative use of mechanochemical activation techniques is pivotal in the enhancement of API stability and bioavailability, making a significant impact on the pharmaceutical industry.

🏆 Honors & Awards:

Throughout her career, Dr. Perissutti has earned several accolades for her scientific contributions. She is recognized for her pioneering work in pharmaceutical technology and solid-state chemistry. While specific awards are not listed in detail, her academic success and research breakthroughs have established her as a respected figure in her field.

💼 Professional Experience:

Dr. Perissutti is currently serving as an Associate Professor at the University of Trieste in the Department of Chemical and Pharmaceutical Sciences. In addition to her academic role, she is heavily involved in teaching, mentoring students, and conducting cutting-edge research. She has successfully balanced her demanding professional responsibilities with her personal life, raising four children while maintaining her dedication to science and education.

📚 Top Noted Publications :

Title: Supramolecular eutectogel as new oral paediatric delivery system to enhance benznidazole bioavailability
Authors: Albertini, B., Bertoni, S., Nucci, G., Perissutti, B., Dalpiaz, A.
Citations: 2
Index: International Journal of Pharmaceutics, 2024, 661, 124417

Title: Enantiospecific crystallisation behaviour of malic acid in mechanochemical reactions with vinpocetine
Authors: D’Abbrunzo, I., Birolo, R., Chierotti, M.R., Perissutti, B., Hasa, D.
Citations: 0
Index: European Journal of Pharmaceutics and Biopharmaceutics, 2024, 201, 114344

Title: Shifting the Focus from Dissolution to Permeation: Introducing the Meso-fluidic Chip for Permeability Assessment (MCPA)
Authors: Tzanova, M.M., Larsen, B.S., Birolo, R., Hiorth, M., Di Cagno, M.P.
Citations: 1
Index: Journal of Pharmaceutical Sciences, 2024, 113(5), pp. 1319–1329

Title: Mechanochemical Synthesis of Praziquantel Hemihydrate in the Presence of Five Solvents with Different Water Miscibility
Authors: D’Abbrunzo, I., Voinovich, D., Perissutti, B.
Citations: 0
Index: Crystals, 2024, 14(4), 374

Title: Praziquantel Fifty Years on: A Comprehensive Overview of Its Solid State
Authors: D’Abbrunzo, I., Procida, G., Perissutti, B.
Citations: 3
Index: Pharmaceutics, 2024, 16(1), 27

Conclusion:

Beatrice Perissutti is a strong candidate for the Research for Women Researcher Award due to her deep expertise in pharmaceutical technology, her innovative research approach, and her ability to balance her professional and personal life effectively. However, there is potential for her to strengthen her industry visibility and expand interdisciplinary collaborations to amplify the broader impact of her work. With her dedication and achievements, Beatrice serves as a remarkable role model for women in research, making her a deserving nominee for this prestigious award.

Assist. Prof. Dr Marco Narducci | Neuropharmacology | Best Research Article Award |

Posted on by ScienceFather

Assist. Prof. Dr Marco Narducci | Neuropharmacology | Best Research Article Award |

Temple University, Japan

Professional Profiles:

SCOPUS

GOOGLE SCHOLAR

👨‍🎓 Bio Summary:

Assist. Prof. Dr. Marco Narducci is a distinguished academic and industry expert specializing in neuropharmacology, strategic innovation, and interdisciplinary research. With a passion for bridging science and business, he has developed novel therapies, founded startups, and led groundbreaking research at the intersection of biotechnology and marketing strategy. His global career spans academia and industry, with a focus on inspiring the next generation of leaders through innovative teaching and impactful research.

🎓 Educational Background:

Ph.D. in Neuropharmacology (University of Ferrara, Italy): Focused on innovative therapies for psychiatric and neurological disorders.

Ph.D. in Neuroaffective Treatments (International Christian University, Japan): Explored treatments for overcoming addictive behaviors.

Master’s in Strategic Marketing and New Product Development (Istituto Europeo di Design, Italy): Specialized in marketing innovations.

Master’s in Environmental Social Science (University of Liverpool, UK): Examined the intersection of environmental and social sciences.

Bachelor’s in Health Communication (Eastern Washington University, USA): Combined communication strategies with health sciences.

🔍 Research Focus:

Dr. Narducci’s research integrates neuropharmacology, biopharmaceutical innovation, and market-driven strategies. His work emphasizes developing advanced neuroaffective therapies, crafting corporate acceleration strategies for startups, and exploring the role of interdisciplinary approaches in addressing global health challenges.

🏆 Honors & Awards:

Innovator in Biotech and Neuromarketing: Recognized for founding three university spin-offs and filing four industrial patents.

Global Leadership: Held senior roles in prestigious organizations, contributing to impactful advancements in biopharma and strategic marketing.

💼 Professional Experience:

Assistant Professor (Temple University, Japan): Focused on corporate strategies for biopharma startups and neuromarketing.

Founder & Scientific Director (UniChem Estense SRL, Italy & Japan): Pioneered advanced biotechnologies and medical foods.

Scientific Director (Meydan Group, UAE): Led innovation-driven projects for food and pharmaceutical manufacturing.

Chief Scientific Officer (Fuji Chemical Industries, Japan): Oversaw research in pharmaceuticals and nutraceuticals.

📚 Top Noted Publications :

The Evolution of Ketosis: Potential Impact on Clinical Conditions
Authors: LN Dilliraj, G Schiuma, D Lara, G Strazzabosco, J Clement, PP Giovannini, M Narducci, et al.
Citations: 33
Journal: Nutrients
Index: 14(17), 3613
Year: 2022

Nicotinamide Adenine Dinucleotide: The Redox Sensor in Aging-Related Disorders
Authors: G Schiuma, D Lara, J Clement, M Narducci, R Rizzo
Citations: 6
Journal: Antioxidants & Redox Signaling
Index: N/A
Year: 2024

Non-Classical HLA Class I Molecules and Their Potential Role in Viral Infections
Authors: S Beltrami, S Rizzo, G Strazzabosco, V Gentili, A Alogna, M Narducci, et al.
Citations: 5
Journal: Human Immunology
Index: 84(8), 384-392
Year: 2023

An Alternative Enzymatic Route to the Ergogenic Ketone Body Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
Authors: F Zaccone, V Venturi, PP Giovannini, C Trapella, M Narducci, H Fournier, et al.
Citations: 5
Journal: Catalysts
Index: 11(1), 140
Year: 2021

Natural Astaxanthin, Antioxidant Protection Power for Healthy Eyes
Authors: GA Serrano, M Narducci
Citations: 5
Journal: Agro Food Industry High Technology
Index: 25, 11-14
Year: 2014

Going Radical, Risky or Random?: The Link Between Mood-Swings and Thought-Action Turnabouts: Field-Experiments in Retail Shopping and Online Gambling
Authors: M Narducci
Citations: 1
Journal: 国際基督教大学 (International Christian University)
Index: N/A
Year: 2012

Conclusion:

Marco Narducci, Ph.D., is a compelling candidate for the “Research for Best Research Article Award.” His interdisciplinary approach, global expertise, and demonstrated innovation in neuropharmacology and biotech make him well-suited for recognition. However, to maximize his chances:

Emphasis should be placed on high-impact, peer-reviewed publications.

A focused narrative highlighting his most significant and transformative research contributions should be presented.

Overall, Marco’s combination of academic rigor, industry relevance, and innovative research positions him as a strong contender for the award.

Prof. Dr Eman Atef | Pharmaceutical Science | Best Researcher Award |

Posted on by ScienceFather

Prof. Dr Eman Atef | Pharmaceutical Science | Best Researcher Award |

West Coast University,United States

Professional Profiles:

SCOPUS

ORCID

GOOGLE SCHOLAR

👨‍🎓 Bio Summary:

Prof. Dr. Eman Atef is an accomplished academic in the field of Pharmaceutics, Pharmacokinetics, and Pharmacogenomics, with a strong background in teaching, research, and leadership. With years of experience in both faculty and administrative roles, she has played a pivotal part in shaping the educational frameworks at various universities. Her work is centered on improving faculty development, enhancing curriculum design, and mentoring students and colleagues to reach their full potential.

🎓 Educational Background:

Prof. Dr. Atef holds a Ph.D. in Industrial Pharmacy and Pharmaceutics, with a minor in Pharmacology, from Massachusetts College of Pharmacy and Health Sciences (MCPHS) in Boston, MA (2004). She also earned an MSc in Industrial Pharmacy and Pharmaceutics from MCPHS (2001) and a B.Sc. in Pharmacy and Pharmaceutical Sciences from Cairo University, Egypt (1993), graduating with distinction and honors in the top 3% of her class.

🔍 Research Focus:

Her research primarily focuses on Pharmaceutics, Pharmacokinetics, and Pharmacogenomics. Dr. Atef has contributed to advancing knowledge in these areas, particularly in how pharmacogenomic insights can be applied to clinical practice. She has led research teams and mentored students at various levels, focusing on improving drug formulations and understanding the complex interactions between drugs and individual genetic factors.

🏆 Honors & Awards:

Dr. Atef’s dedication to education and research has been recognized with numerous accolades, including certificates in Leadership from the University of Pittsburgh’s Institute for Clinical Research Education (2017-2018) and Implementing Pharmacogenomics into Clinical Practice (2021) from the University of Florida. She has also received recognition for her extensive work in mentoring and her active participation in national academic committees.

💼 Professional Experience:

Prof. Dr. Atef is currently a faculty member at West Coast University School of Pharmacy in Los Angeles, CA, where she has been involved in various administrative roles. She has served as Chair of the Professional Development Committee (2020-2022) and is an active member of the Curriculum Committee. Her leadership extends to being the Faculty Representative on the Executive Committee (2021-2023), Vice Chair of the Assessment Committee (2021-present), and faculty mentor for assistant professors. In her previous position at California Northstate University, she was Chair of the Assessment Committee (2017-2019), leading efforts to improve the College Assessment Plan and student learning experiences.

📚 Top Noted Publications :

Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS)

Authors: E. Atef, A.A. Belmonte

Citations: 188

Journal: European Journal of Pharmaceutical Sciences

Volume/Issue: 35 (4), 257-263

Year of Publication: 2008

 

Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions

Authors: H. Chauhan, C. Hui-Gu, E. Atef

Citations: 128

Journal: Journal of Pharmaceutical Sciences

Volume/Issue: 102 (6), 1924-1935

Year of Publication: 2013

 

Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug–polymer interaction for synergistic effects

Authors: D. Prasad, H. Chauhan, E. Atef

Citations: 123

Journal: Journal of Pharmaceutical Sciences

Volume/Issue: 103 (11), 3511-3523

Year of Publication: 2014

 

Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction

Authors: H. Chauhan, A. Kuldipkumar, T. Barder, A. Medek, C.H. Gu, E. Atef

Citations: 87

Journal: Pharmaceutical Research

Volume: 31, 500-515

Year of Publication: 2014

 

Role of molecular interactions for synergistic precipitation inhibition of poorly soluble drug in supersaturated drug–polymer–polymer ternary solution

Authors: D. Prasad, H. Chauhan, E. Atef

Citations: 74

Journal: Molecular Pharmaceutics

Volume/Issue: 13 (3), 756-765

Year of Publication: 2016

Conclusion:

Eman Atef has a well-rounded profile with substantial leadership, mentoring, and teaching experience, making her a strong contender for the Best Researcher Award. Her active role in improving the educational experience of students and faculty, along with her research experience in Pharmaceutics and Pharmacogenomics, positions her as an excellent candidate. However, her research contributions could be further highlighted by focusing on the impact of her research outputs and increasing her international and public engagement.

Assist. Prof. Dr xiaolei zhou | Anti-cancer drug | Best Researcher Award |

Posted on by ScienceFather

Assist. Prof. Dr xiaolei zhou | Anti-cancer drug | Best Researcher Award |

Fuzhou Univeristy,China

Professional Profiles:

SCOPUS

ORCID

 👨‍🎓 Bio Summary:

Assist. Prof. Dr. Xiaolei Zhou is a dynamic researcher and academic specializing in cancer immunology and bioengineering. Currently serving as a tenure-track professor at the College of Biological Science and Engineering, Fuzhou University, China, Dr. Zhou has a remarkable trajectory in translational research, with a strong focus on p53-based cancer therapies and immune escape mechanisms. His innovative contributions have earned him international recognition, competitive grants, and high-impact publications in leading journals.

🎓 Educational Background:

Dr. Zhou holds a Ph.D. in Medical Science from Karolinska Institutet, Sweden (2016–2021), where he conducted groundbreaking research on cancer therapies. His academic journey also includes a Master’s degree in Bioengineering from the University of Chinese Academy of Sciences (2012–2015) and a Bachelor’s degree in Bioengineering from Harbin Institute of Technology (2005–2009). He further enhanced his expertise through postdoctoral training at École Polytechnique Fédérale de Lausanne (EPFL), Switzerland (2022–2024), and Karolinska Institutet (2022).

🔍 Research Focus:

Dr. Zhou’s research is centered on cancer immunology, tumor immune evasion, and the development of targeted therapies. His work explores the therapeutic potential of p53 activation, revitalization of exhausted T cells, and novel photosensitizers for cancer treatment. With a multidisciplinary approach that integrates bioengineering and medical science, his research aims to translate cutting-edge findings into clinical applications, improving patient outcomes in oncology.

🏆 Honors & Awards:

Dr. Zhou has received numerous accolades for his contributions to science, including the prestigious SPARK funding from the Swiss National Science Foundation (2023–2024) and the EPFLeaders4impact Postdoc Fellowship funded by the European Union’s Horizon 2020 program (2022–2024). His work has also been recognized as the “Paper of the Year 2021” at Karolinska Institutet. Additionally, he was awarded a four-year Ph.D. scholarship by the Chinese Scholarship Council for his outstanding academic performance.

💼 Professional Experience:

Dr. Zhou began his career as a process technician at Qilu Pharmaceutical Co., Ltd., before transitioning to academic roles as a research assistant at Karolinska Institutet and the Fujian Institute of Research on the Structure of Matter. After completing his Ph.D., he undertook postdoctoral research at EPFL and Karolinska Institutet, contributing to advanced cancer therapies. In March 2024, he was appointed as a tenure-track professor at Fuzhou University, where he continues to lead innovative research and mentor emerging scientists.

📚 Top Noted Publications :

Title: Crystal Structures of the Serine Protease Domain of Murine Plasma Kallikrein

Authors: Xu, M.-M., Xu, P., Zhou, X.-L., Jiang, L.-G., Huang, M.-D.

Year: 2017

Journal: Jiegou Huaxue

Volume/Issue: 36(2), pp. 242–249

Citations: 2

 

Title: Tumor-Specific Imaging and Photodynamic Therapy Targeting the Urokinase Receptor

Authors: Iqbal, Z., Jiang, L., Chen, Z., Hu, P., Huang, M.

Year: 2017

Book Chapter: Imaging in Photodynamic Therapy, pp. 259–274

Citations: 1

 

Title: An ELISA Method Detecting the Active Form of suPAR

Authors: Zhou, X., Xu, M., Huang, H., Yuan, C., Huang, M.

Year: 2016

Journal: Talanta

Volume/Issue: 160, pp. 205–210

Citations: 10

 

Title: A Drug Carrier Targeting Murine uPAR for Photodynamic Therapy and Tumor Imaging

Authors: Zhou, X., Zheng, K., Li, R., Xue, J., Huang, M.

Year: 2015

Journal: Acta Biomaterialia

Volume/Issue: 23, pp. 116–126

Citations: 19

 

Title: Dual Actions of Albumin Packaging and Tumor Targeting Enhance the Antitumor Efficacy and Reduce the Cardiotoxicity of Doxorubicin In Vivo

Authors: Zheng, K., Li, R., Zhou, X., Chen, Z., Huang, M.

Year: 2015

Journal: International Journal of Nanomedicine

Volume/Issue: 10, pp. 5327–5342

Citations: 26

Conclusion:

Dr. Xiaolei Zhou is a strong candidate for the Best Researcher Award. His groundbreaking work in cancer immunology, coupled with his global collaborations and high-impact publications, positions him among leading researchers in his field. Addressing the suggested areas for improvement could further enhance his candidacy and elevate his stature in the research community.

Prof. Dr ADNAN AYHANCI | Biology | Best Researcher Award |

Posted on by ScienceFather

Prof. Dr ADNAN AYHANCI | Biology | Best Researcher Award |

ESKİŞEHİR OSMANGAZI UNIVERSITY,Turkey

Professional Profiles:

SCOPUS

GOOGLE SCHOLAR

 👨‍🎓 Bio Summary:

Prof. Dr. Adnan Ayhancı is a distinguished professor at Eskişehir Osmangazi University, specializing in toxicology, biosynthesis, and nanotechnology. His research focuses on the protective effects of various compounds against chemical toxicities and the development of innovative nanoparticle synthesis techniques. With over three decades of academic experience, Prof. Ayhancı has significantly contributed to the fields of biology and toxicology, mentoring numerous graduate students and publishing impactful research in prestigious scientific journals. His dedication to advancing scientific knowledge has earned him numerous awards and recognitions.

🎓 Educational Background:

Prof. Ayhancı completed his B.Sc. in Biology at Anadolu University in 1989. He earned his M.Sc. in Zoology from Anadolu University in 1992, with a thesis investigating the reduction of cyclophosphamide’s carcinogenic effects using calcium channel blockers. He pursued a Ph.D. in Biology at Eskişehir Osmangazi University, graduating in 1997 with research on the cytotoxic interactions between cyclophosphamide and zinc. His education reflects a strong foundation in biological sciences and toxicological research.

🔍 Research Focus:

Prof. Ayhancı’s research primarily explores toxicology, focusing on mitigating the harmful effects of toxic substances like Bisphenol A (BPA) through protective agents such as boric acid. He is also actively involved in the green biosynthesis of nanoparticles, including selenium and zinc oxide, exploring their anticancer and antimicrobial properties. His work contributes to advancements in environmental health, nanotechnology, and biomedical applications.

🏆 Honors & Awards:

Prof. Ayhancı has received several prestigious awards recognizing his contributions to science. Notably, he won the “Year’s Best Scientific Research Award” from the Turkish Medical Students Association in 2016 and the “Best Scientific Study Award” from Eryetiş Balkanlar Educational Institutions in 2018. He has also been honored with TÜBİTAK awards for his international scientific publications in 2011 and 2015.

 

💼 Professional Experience:

Prof. Ayhancı has been a professor at Eskişehir Osmangazi University since 2016. He served as an associate professor from 2011 to 2016 and as an assistant professor from 1997 to 2011. His early career included roles as a research assistant at both Anadolu University and Eskişehir Osmangazi University. He has also held key administrative positions, including Department Chair and Division Head, contributing to the university’s academic development.

 

📚 Top Noted Publications :

Title: Seleno l-Methionine Acts on Cyclophosphamide-Induced Kidney Toxicity

Authors: A. Ayhancı, S. Günes, V. Sahinturk, S. Appak, R. Uyar, M. Cengiz, Y. Altuner

Journal: Biological Trace Element Research

Citations: 68

Year of Publication: 2010

 

Title: A Comparative Study on the Therapeutic Effects of Silymarin and Silymarin-Loaded Solid Lipid Nanoparticles on D-GaIN/TNF-α-Induced Liver Damage in Balb/c Mice

Authors: M. Cengiz, H.M. Kutlu, D.D. Burukoglu, A. Ayhancı

Journal: Food and Chemical Toxicology

Citations: 66

Year of Publication: 2015

 

Title: Cardioprotective Effect of Selenium Against Cyclophosphamide-Induced Cardiotoxicity in Rats

Authors: S. Günes, V. Sahinturk, P. Karasati, I.K. Sahin, A. Ayhancı

Journal: Biological Trace Element Research

Citations: 60

Year of Publication: 2017

 

Title: Cyclophosphamide-Induced Oxidative Stress, Lipid Peroxidation, Apoptosis, and Histopathological Changes in Rats: Protective Role of Boron

Authors: M. Cengiz, V. Sahinturk, S.C. Yildiz, İ.K. Şahin, N. Bilici, S.O. Yaman, Y. Altuner

Journal: Journal of Trace Elements in Medicine and Biology

Citations: 57

Year of Publication: 2020

 

Title: Protective Effects of Selenium on Cyclophosphamide-Induced Oxidative Stress and Kidney Injury

Authors: S. Günes, V. Sahinturk, S. Uslu, A. Ayhancı, S. Kacar, R. Uyar

Journal: Biological Trace Element Research

Citations: 50

Year of Publication: 2018

Conclusion:

Prof. Adnan Ayhancı’s comprehensive expertise in biological toxicology, nanoparticle research, and biosynthesis, coupled with a track record of academic leadership and mentorship, makes him a strong candidate for the Best Researcher Award. His dedication to impactful research and scientific contribution is evident through his accolades and ongoing projects. Enhancing international collaboration and focusing on high-impact publications would further solidify his standing as a distinguished researcher in his field.dvancing patient care through research and mentorship underscores his qualification as a distinguished researcher and educator.

Dr Shoaib Khan | Drug Designing Award | Best Researcher Award |

Posted on by ScienceFather

Dr. Shoaib Khan | Drug Designing Award |  Best Researcher Award.

Abbottabad University of Science and Technology ,Pakistan

Professional Profiles:

SCOPUS

GOOGLE SCHOLAR

👨‍🎓 Bio Summary:

Dr. Shoaib Khan is a dedicated professional with a Ph.D. in Organic Chemistry and a strong background in systems management. He is committed to using his education experience and computer skills to bring students into the twenty-first century. Dr. Khan’s research focuses on the design, synthesis, and biological evaluation of various organic compounds, with a particular interest in their potential applications in medicine and agriculture.

🎓 Education:

Dr. Khan completed his Ph.D. in Organic Chemistry from Hazara University, Mansehra, following his earlier degrees in Botany, Zoology, and Chemistry. He also holds a B.Ed. and M.Ed. in Science from Allama Iqbal Open University, Islamabad.

🔍 Research Focus:

Dr. Khan’s research primarily centers on the synthesis and evaluation of novel compounds with potential biological activities. His work often involves molecular docking studies and in vitro biological evaluations to assess the compounds’ efficacy against various targets, such as enzymes and cancer cells.

🏆 Honors & Awards:

Dr. Khan has received recognition for his research contributions, including awards for the quality and impact of his publications. He has also been honored for his teaching and supervisory roles in academia.

Professional Experience: 💼

Dr. Khan has extensive experience in academia, including supervising and mentoring students at various levels. He has served as an external examiner and has contributed significantly to the advancement of organic chemistry through his research and teaching.

📚 Top Noted Publications :

Title: Synthesis, in vitro α-amylase, α-glucosidase activities and molecular docking study of new benzimidazole bearing thiazolidinone derivatives
Authors: S Khan, H Ullah, F Rahim, M Nawaz, R Hussain, L Rasheed
Journal: Journal of Molecular Structure
Volume: 1269
Pages: 133812
Year: 2022
Citations: 42

 

Title: Synthesis, in vitro anti-microbial analysis and molecular docking study of aliphatic hydrazide-based benzene sulphonamide derivatives as potent inhibitors of α-glucosidase
Authors: S Khan, S Iqbal, M Shah, W Rehman, R Hussain, L Rasheed, H Alrbyawi, …
Journal: Molecules
Volume: 27
Issue: 20
Pages: 7129
Year: 2022
Citations: 36

 

Title: Multipotent cholinesterase inhibitors for the treatment of Alzheimer’s disease: Synthesis, biological analysis and molecular docking study of benzimidazole-based thiazole
Authors: R Hussain, H Ullah, F Rahim, M Sarfraz, M Taha, R Iqbal, W Rehman, …
Journal: Molecules
Volume: 27
Issue: 18
Pages: 6087
Year: 2022
Citations: 32

 

Title: Synthesis, DFT Studies, molecular docking and biological activity evaluation of thiazole-sulfonamide derivatives as potent Alzheimer’s inhibitors
Authors: S Khan, H Ullah, M Taha, F Rahim, M Sarfraz, R Iqbal, N Iqbal, R Hussain, …
Journal: Molecules
Volume: 28
Issue: 2
Pages: 559
Year: 2023
Citations: 28

 

Title: New biologically potent benzimidazole‐based‐triazole derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors along with molecular docking study
Authors: Y Khan, W Rehman, R Hussain, S Khan, A Malik, M Khan, A Liaqat, …
Journal: Journal of Heterocyclic Chemistry
Volume: 59
Issue: 12
Pages: 2225-2239
Year: 2022
Citations: 23

Title: Design, synthesis, in silico testing, and in vitro evaluation of thiazolidinone-based benzothiazole derivatives as inhibitors of α-amylase and α-glucosidase
Authors: S Khan, S Iqbal, M Khan, W Rehman, M Shah, R Hussain, L Rasheed, …
Journal: Pharmaceuticals
Volume: 15
Issue: 10
Pages: 1164
Year: 2022
Citations: 22

.Author Metrics 📊 : 

Dr. Khan’s publications have a significant impact factor, indicating the quality and influence of his research in the scientific community. His work has been cited by other researchers, further highlighting its importance and relevance.

📅 Research Timeline:

Dr. Khan’s research journey has been marked by a series of achievements, starting from his early education in science to his current position as a respected researcher and educator in the field of organic chemistry.